Gender Dysphoria Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – TerSera Therapeutics, Endo International

DelveInsight Business Research LLP

DelveInsight’s “Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Gender dysphoria, historical and forecasted epidemiology as well as the Gender dysphoria market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Gender Dysphoria Key Highlights 

• Key Companies working in the Gender Dysphoria market include Valera Pharmaceuticals, Endo International TerSera Therapeutics, and many others 

• Key Therapies included in the Gender Dysphoria market include Lynestrenol, Estradiol Valerate, and many others 

Gender Dysphoria Overview

Gender dysphoria, according to the Diagnostic and Statistical Manual of Mental Disorders (DSM 5), is defined as a “marked incongruence between their experienced or expressed gender and the one they were assigned at birth.” It was previously termed “gender identity disorder.”

Children or adolescents who experience this turmoil cannot correlate to their gender expression when identifying themselves within traditional societal binary male or female roles, which may cause cultural stigmatization.

This can further lead to relationship conflicts with family, peers, and friends in various aspects of their daily lives and lead to rejection from society, interpersonal conflicts, symptoms of depression and anxiety, substance use disorders, a negative sense of well-being, and poor self-esteem, and increased risk of self-harm and suicidality.

 Gender Dysphoria Epidemiology Insights

• The total estimate was about 0.005% to 0.014% of people assigned male at birth (5-14 per 100k) and 0.002% to 0.003% of people assigned female at birth (2-3 per 100k) are diagnosable with gender dysphoria.

• Studies of hormonal treatment or legal name change find higher prevalence than sex reassignment, with, for example, a 2010 Swedish study finding that 1 in 7,750 (13 per 100k) adult natal males and 1 in 13,120 (8 per 100k) adult natal females requested a legal name change to a name of the opposite gender

Click here to learn more about the Gender Dysphoria Market Landscape

The Report Covers the Gender Dysphoria Epidemiology Segmented by:

• Gender Dysphoria prevalent cases 

• Gender Dysphoria incident cases 

• Gender Dysphoria treatment cases 

• Gender Dysphoria-diagnosed cases 

Gender Dysphoria Market Outlook 

The Gender dysphoria market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Gender dysphoria market trends by analyzing the impact of current Gender dysphoria therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Gender dysphoria market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Gender dysphoria market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Gender dysphoria market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Gender Dysphoria Market 

• Valera Pharmaceuticals

• Endo International 

• TerSera Therapeutics

And many others 

Gender Dysphoria Therapies Covered and Analyzed in the Report

•  Lynestrenol

• Estradiol Valerate

And many others 

Learn more about the Key Companies and Emerging Therapies in the Gender Dysphoria Market

Table of Contents 

1.  Key Insights 

2.  Gender Dysphoria Introduction 

3.  Executive Summary of Gender Dysphoria         

4.  Disease Background and Overview

5.  Epidemiology and patient population

6.  Gender Dysphoria Emerging Therapies

7.  Gender Dysphoria Market Outlook

8.  Market Access and Reimbursement of Therapies

9.  Market Drivers 

10.  Market Barriers 

11.  Appendix

12.  Report Methodology

13.  DelveInsight Capabilities

14.  Disclaimer

Learn about the detailed offerings of the report @ Gender Dysphoria Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services